Cartas al editor
Response to “New tobacco products, a threat for tobacco control and
public health of Mexico"
Riccardo Polosa, MD, PhD1
2
Salvatore Urso, MSc2
Konstantinos E Farsalinos, MD, MPH3
4
5
1Department of Clinical and Experimental
Medicine, University of Catania. Catania, Italy.
2Center of Excellence for the Acceleration of
Harm Reduction (Coehar), University of Catania. Catania, Italy.
3Department of Cardiology, Onassis Cardiac
Surgery Centre. Kallithea, Greece
4Department of Pharmacy, University of Patras.
Patras, Greece.
5National School of Public Health. Athens,
Greece.
Dear Editor: The position article by Reynales-Shigematsu and colleagues1 on the public health impact in Mexico
of combustion-free electronic nicotine delivery systems (ENDS) fails to present a
balanced overview of the risk-benefit ratio of these new technologies, grossly
misrepresents the existing evidence, and ignores the broad consensus that these products
are much less harmful than cigarettes.2,3,4
The work cited by the authors (references 8-21) on exposure risks from e-cigarette
aerosol emissions report misleading results that do not reflect normal conditions of
use.5 The authors claim that trial of e-cigarettes is propitiating tobacco initiation
among Mexican adolescents, citing a longitudinal cohort study on Mexican high school
students (reference 31) which actually disproves this claim, as it reported that the
association between e-cigarette trial at baseline and past 30 day smoking at follow-up
was not even statistically significant.5 The authors dismiss the utility of ecigarettes in smoking
cessation, but their cited references do not support this claim.5 Further, a recent high
quality randomized controlled trial6
has shown e-cigarettes to be twice as effective in smoking cessation compared to
nicotine replacement therapies. A detailed critique of the position article is
available.5
Following the authors, ENDS can only be part of a harm reduction strategy for Mexico if
they immediately promote total smoking abstinence, as well as complete absence of dual
usage and recruitment of non-smokers.7
However, these are maximalist and unrealistic conditions that no new harm reduction
product can fulfill. A more realistic approach to harm reduction yields concrete
benefits: the recreational usage of e-cigarettes, endorsed by health institutions in the
United Kingdom under a consistent Tobacco Control strategy, has contributed to a
significant decay of smoking prevalence with negligible usage by non-smokers of all
ages.2,3
By presenting ENDS as a threat to public health (consequently recommending their
regulation as combustible tobacco products), Reynales- Shigematsu and colleagues are
depriving 15 million Mexican smokers of key information on a plausible harm reduction
alternative that can vastly improve their health. As an unintended consequence, this
misinformation will keep them smoking.
References
1. Reynales-Shigematsu LM, Barrientos-Gutiérez I, Zavala-Arciniega
L, Arillo-Santillán E. Nuevos productos de tabaco, una amenaza para el control
de tabaco y la salud pública en México. Salud Publica Mex. 2018;60(5):598-604.
https:// doi.org/10.21149/9682
[ Links ]
2. Royal College of Physicians. Nicotine without smoke: Tobacco harm
reduction. London: RCP, 2016 [cited October 7, 2018]. Available from:
Available from: http://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction-0
[ Links ]
3. McNeill A, Brose LS, Calder R, Bauld L, Robson D. Evidence review
of e-cigarettes and heated tobacco products 2018. A report commissioned by
Public Health England. London: Public Health England, 2018 [cited October 7,
2018]. Available from: Available from: https://www.gov.uk/government/
publications/e-cigarettes-and-heated-tobaccoproducts-evidence-review
[ Links ]
4. National Academies of Sciences, Engineering and Medicine. Public
health consequences of e-cigarettes. Washington DC: The National Academies
Press, 2018. https://doi.org/10.17226/24952
[ Links ]
5. Polosa R, Urso S, Farsalinos KE. Response to “New tobacco
products, a threat for tobacco control and public health of Mexico” [internet].
Greece; c2015-2016 [updated 2019 Apr 26; cited 2018 Oct 7]. E-cigarrete research
[about 7 screens]. Available from: Available from: http://www.ecigarette-research.org/research/index.php/
whats-new/2019/269-mexico-ecig
[ Links ]
6 . Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers-Smith K,
Bisal N, et al. A randomized trial of e-cigarettes versus nicotine replacement
therapy. N Engl J Med. 2019;380:629-37. https:// doi.org/10.1056/NEJMoa1808779
[ Links ]
7. Norma Oficial Mexicana NOM-028-SSA2-2009 Para la prevención,
tratamiento y control de las adicciones. México: Conadic, 2009 [cited October 7,
2018]. Available from: Available from: http://www.conadic. salud.gob.mx/pdfs/norma_oficial_nom.pd
[ Links ]